Gene · 2073
Papers2,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nucleases and Co-Factors in DNA Replication Stress Responses. | DNA (Basel) | 2022 | 36203968 | PubTator, text mining | PubMed |
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. | Ther Adv Med Oncol | 2022 | 36199621 | PubTator, text mining | PubMed |
| Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease. | Chem Res Toxicol | 2022 | 36197742 | PubTator, text mining | PubMed |
| A protein with broad functions: damage-specific DNA-binding protein 2. | Mol Biol Rep | 2022 | 36190612 | PubTator, text mining | PubMed |
| Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature. | Clin Case Rep | 2022 | 36188050 | PubTator, text mining | PubMed |
| The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells. | NAR Cancer | 2022 | 36186110 | PubTator, text mining | PubMed |
| XPF activates break-induced telomere synthesis. | Nat Commun | 2022 | 36184605 | PubTator, text mining | PubMed |
| PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma. | Clin Transl Med | 2022 | 36178086 | PubTator, text mining | PubMed |
| CAMTA1 gene affects the ischemia-reperfusion injury by regulating CCND1. | Front Cell Neurosci | 2022 | 36159397 | PubTator, text mining | PubMed |
| UVA Radiation, DNA Damage, and Melanoma. | ACS Omega | 2022 | 36157735 | PubTator, text mining | PubMed |
| Effects of replication domains on genome-wide UV-induced DNA damage and repair. | PLoS Genet | 2022 | 36155646 | PubTator, text mining | PubMed |
| Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells. | Int J Mol Sci | 2022 | 36142793 | PubTator, text mining | PubMed |
| Identification of Human Global, Tissue and Within-Tissue Cell-Specific Stably Expressed Genes at Single-Cell Resolution. | Int J Mol Sci | 2022 | 36142130 | PubTator, text mining | PubMed |
| Microarray and in silico analysis of DNA repair genes between human testis of patients with nonobstructive azoospermia and normal cells. | Cell Biochem Funct | 2022 | 36121211 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
| Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population. | Dis Markers | 2022 | 36118674 | PubTator, text mining | PubMed |
| Ligands stimulating antitumour immunity as the next G-quadruplex challenge. | Mol Cancer | 2022 | 36114513 | PubTator, text mining | PubMed |
| DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination. | Front Oncol | 2022 | 36110934 | PubTator, text mining | PubMed |
| Non-canonical DNA/RNA structures associated with the pathogenesis of Fragile X-associated tremor/ataxia syndrome and Fragile X syndrome. | Front Genet | 2022 | 36110216 | PubTator, text mining | PubMed |
| Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients. | Front Pharmacol | 2022 | 36105185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2073/papers?page=18